Convenience: Using insulin pens may be a more convenient option than using a vial and syringe, allowing you to inject versus using a separate needle Portability: It is simple and easy to carry ...

The global Insulin Delivery Device Market, valued at US$32.6 billion in 2024 stood at US$35.3 billion in 2025 and is ...

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

India’s drug regulator has given the nod to Eli Lilly’s once-a- week Mounjaro (tirzepatide) injection in the KwikPen format, ...

"These treatments are only available on the NHS under strict criteria, and access will be through specialist NHS weight ...

In its first-quarter 2025 investor letter, River Road Small Cap Value Fund highlighted stocks such as Embecta Corp.

The smart insulin pens market is projected to reach USD 4,606.3 million by 2025 and is expected to grow steadily at a CAGR of 8.3% to reach USD 10,224.3 million by 2035. In 2024, the smart insulin ...

In a Phase 2a clinical trial, the GLP-1 RA bofanglutide injection demonstrated a favorable safety and tolerability profile ...

The drug helps control high blood sugar levels in adults with diabetes over a seven-day period as opposed to the daily basal ...